Oragenics Reports Clinical Advancements and NYSE American Listing Status

Oragenics provided an update on its ongoing clinical trials while confirming its continued compliance and listing status on the NYSE American exchange.

28 Aug, 20:25 — 28 Aug, 20:25

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual9d ago

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - Taiwan News

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update Taiwan News

Read full article →

Oragenics Reports Clinical Advancements and NYSE American Listing Status

Sources

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - Taiwan News

Related Stories

Severe Drought and Heatwaves Plunge French Wine Harvest to 30-Year Low

Volkswagen to Sell German Plant for Conversion to Air Defense Production

Rare White Falcon Fetches Record AED 2.1 Million at Abu Dhabi Auction

Jaguar Land Rover Announces 4,000 Job Cuts Amid Corporate Restructuring